HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
LNTH
Lantheus Holdings, Inc.
LNTH's fundamentals are mixed: it turned 25% of its revenue into free cash flow, but its operating margin fell 4 points to 19%. At 25x earnings, it's trading in line with its usual 24x. Analysts expect strong earnings growth, though they disagree widely on how much.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
LNTH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Healthy | |
| Strong |
LNTH's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
LNTH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $62.87 | -38% |
| Forward | 16x | $101 | — |
| Fair | 24x | $98.08 | -3.1% |
| Current | 25x | $101 | — |
| Expensive | 141x | $579 | +472% |
Historical ranges are pointers, not guarantees.
LNTH's PE is in its fair range at 25x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
LNTH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
LNTH has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
LNTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.35 | +55% |
| Q3 2026 | $4.10 | +73% |
| Q2 2026 | $4.18 | +11% |
| Q1 2026 | $4.19 | +19% |
| Q4 2025 | $3.41 | -22% |
| Q3 2025 | $2.37 | -61% |
| Q2 2025 | $3.75 | -39% |
| Q1 2025 | $3.51 | -46% |
| Q4 2024 | $4.36 | -6.2% |
LNTH has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over LNTH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
LNTH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $389.9M | +1.5% |
| Q2 2026 | $388.2M | +2.7% |
| Q1 2026 | $377.3M | +1.2% |
| Q4 2025 | $406.8M | +4% |
| Q3 2025 | $384M | +1.4% |
| Q2 2025 | $378M | -4.1% |
| Q1 2025 | $372.8M | +0.8% |
| Q4 2024 | $391.1M | +10% |
LNTH's revenue grew through 2024 and has held roughly level since: $390M last quarter, up 1.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.3% | -3.1 points |
| Q2 2026 | 26% | +2.6 points |
| Q1 2026 | 22% | -5.8 points |
| Q4 2025 | 19% | -10 points |
| Q3 2025 | 11% | -24 points |
| Q2 2025 | 23% | -2.8 points |
| Q1 2025 | 27% | -1.4 points |
| Q4 2024 | 29% | -9.7 points |
LNTH has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over LNTH on cash flow, with more consistent year-over-year improvement.
LNTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $99.9M | +5.6% |
| Q2 2026 | $89.9M | +14% |
| Q1 2026 | $121.9M | +23% |
| Q4 2025 | $81.4M | -42% |
| Q3 2025 | $94.7M | -41% |
| Q2 2025 | $79.1M | +7.6% |
| Q1 2025 | $98.8M | -17% |
| Q4 2024 | $141.4M | +26% |
LNTH generated $393M in free cash flow over the past year, down 5.1% from the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over LNTH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
LNTH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +895K shares |
| 1 year | +1.1% | +750K shares |
| 3 years | -2.3% | -1.6M shares |
| 5 years | +1.2% | +790K shares |
| Available history | +71% | +28.3M shares |
LNTH has 68M diluted shares, up 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | $100M |
| Q3 2025 | $100M |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
LNTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | 0.2x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
LNTH has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
LNTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.4 | Neutral |
| Stochastic | 43.2 | Neutral |
LNTH's weekly RSI is 60 (neutral) and its Stochastic is 43 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
LNTH PE vs Healthcare Sector
| Metric | LNTH | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 26x | 4.4% below |
| PE % | 55 | 29 | 26 pts above |
LNTH is trading at 25x earnings, in line with the Healthcare sector's median of 26x.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
LNTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $100.2 | 1% above |
| 20 week MA | $101.7 | 0.4% below |
| 50 week MA | $88.7 | 14% above |
| 100 week MA | $82.7 | 22% above |
| 200 week MA | $80.9 | 25% above |
LNTH has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
LNTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.3 | $14.7 | -27% |
| 2021 | $14.7 | $29.4 | +100% |
| 2022 | $29.4 | $50.6 | +72% |
| 2023 | $50.6 | $62.0 | +22% |
| 2024 | $62.0 | $92.1 | +48% |
| 2025 | $92.1 | $66.7 | -28% |
| 2026 YTD | $66.7 | $101.3 | +52% |
LNTH has the edge over HIMS on returns for 2026, with the stronger performance.